OS Therapies Inc. Files Q1 2025 10-Q Report
Ticker: OSTX · Form: 10-Q · Filed: May 15, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
OS Therapies Inc. filed its Q1 2025 10-Q on 5/15/25. Check financials.
AI Summary
OS Therapies Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware with its principal executive offices in Grasonville, Maryland, operates in the Pharmaceutical Preparations sector. The filing was made on May 15, 2025, under SEC file number 001-42195.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for OS Therapies Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing and does not inherently indicate new risks.
Key Numbers
- 20250331 — Quarter End Date (The report covers the period ending March 31, 2025.)
- 20250515 — Filing Date (The 10-Q was filed on May 15, 2025.)
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- May 15, 2025 (date) — Filing date
- 001-42195 (other) — SEC File Number
- Delaware (other) — State of incorporation
- Grasonville, Maryland (location) — Principal executive offices
FAQ
What is the SEC file number for OS Therapies Inc.?
The SEC file number for OS Therapies Inc. is 001-42195.
What period does this 10-Q report cover?
This 10-Q report covers the quarterly period ended March 31, 2025.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 15, 2025.
In which state is OS Therapies Inc. incorporated?
OS Therapies Inc. is incorporated in Delaware.
What is the address of OS Therapies Inc.'s principal executive offices?
The principal executive offices of OS Therapies Inc. are located at 115 Pullman Crossing Road, Suite 103, Grasonville, Maryland 21638.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding OS Therapies Inc (OSTX).